SOPHIE BRYANT: Open Payments
NPI 1760169189 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$168 in 8 payments from 5 companies in 2025. Trend: 2023 $68 · 2024 $119 · 2025 $168
Food & beverage: $168
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $91 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: Wegovy, CAPLYTA, GVOKE HYPOPEN, UBRELVY, TRELEGY ELLIPTA.
Industry payments across VA — which companies pay providers there.
